Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Currien MacDonald, MD, CIP

Advertisement

Articles by Currien MacDonald, MD, CIP

Currien MacDonald

Cleared and Graded: Modernizing the 510(k) Pathway

ByCurrien MacDonald, MD, CIP
August 29th 2024

Due to increasing complexity of modern technology, FDA should consider updating its 510(k) process.

Advertisement

Latest Updated Articles

  • Currien MacDonald
    Cleared and Graded: Modernizing the 510(k) Pathway

    August 29th 2024



Advertisement
Advertisement

Trending on PharmExec

1

Pfizer, Verismo Strike Licensing Deals to Push CAR T Manufacturing In Vivo

2

Keeping Human Expertise at the Center of AI

3

Build, Buy, or Rent: Moving AI Beyond the Pilot Stage

4

Your Questions Answered: GLP-1 Deals, FDA Approvals, and Manufacturing Buildout

5

Gilead Signs Royalty-Free Licensing Deals to Broaden Access to Obeldesivir

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us